marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2023-Q2
hinzugefügt 14.08.2023
Zynerba Pharmaceuticals Bilanz 2011-2024 | ZYNE
Bilanz Jährlich Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-50.3 M | -67.2 M | - | -69.7 M | -59.8 M | -62.5 M | -31 M | -41.5 M | -9.33 M | 345 K | - | - |
Langfristige Schulden |
120 K | 354 K | - | - | - | - | - | - | - | 375 K | - | - |
Langfristiger Schuldenstrom |
215 K | 209 K | 110 K | 244 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 110 K | - | 662 K | - | - | 16.5 M | 1.5 M | - | - |
Kurzfristige Verbindlichkeiten |
9.17 M | 9.9 M | 13.9 M | 12.1 M | 9.73 M | 7.44 M | 6.97 M | 3.94 M | - | - | - | - |
Gesamtverbindlichkeiten |
9.29 M | 10.3 M | 13.9 M | 12.2 M | 9.73 M | 8.1 M | 6.97 M | 3.94 M | 19.7 M | 3.06 M | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | 172 K | 834 K | 841 K | 1.12 M | 1.04 M | - | - |
Gewinnrücklagen |
-275 M | -239 M | -202 M | -151 M | -118 M | -78 M | -46 M | -22.6 M | -10 M | -4.36 M | - | - |
Vermögenswerte |
55.5 M | 81.2 M | 74.1 M | 87.8 M | 67.3 M | 69.1 M | 36.6 M | 43.6 M | 11.6 M | 1.86 M | - | - |
Zahlungsmittel |
50.6 M | 67.8 M | 59.2 M | 70.1 M | 59.8 M | 62.5 M | 31 M | 41.5 M | 9.33 M | 155 K | - | - |
Buchwert |
46.2 M | 70.9 M | 60.1 M | 75.6 M | 57.6 M | 60.9 M | 29.6 M | 39.7 M | -8.05 M | -1.2 M | - | - |
Gesamtes Eigenkapital |
46.2 M | 70.9 M | 60.1 M | 75.6 M | 57.6 M | 60.9 M | 29.6 M | 39.7 M | -8.05 M | -4.36 M | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Zynerba Pharmaceuticals
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | 60 K | 120 K | 179 K | 237 K | 296 K | 354 K | 411 K | 468 K | 525 K | - | - | - | 44.2 K | 110 K | 110 K | 110 K | 110 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
11.5 M | 9.67 M | 9.29 M | 9.61 M | 9.77 M | 9.21 M | 10.3 M | 11.3 M | 10.5 M | 13.1 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 9.73 M | 9.73 M | 9.73 M | 9.73 M | 8.1 M | 8.1 M | 8.1 M | 8.1 M | 6.97 M | 5.41 M | - | - | 3.94 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 172 K | - | 172 K | 172 K | 834 K | 834 K | 834 K | 834 K | 834 K | 834 K | 834 K | 841 K | 841 K | 841 K | 841 K | 1.12 M | 1.12 M | 1.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-295 M | -285 M | -275 M | -267 M | -258 M | -248 M | -239 M | -231 M | -220 M | -210 M | -202 M | -202 M | -202 M | -202 M | -151 M | -151 M | -151 M | -151 M | -118 M | -118 M | -118 M | -118 M | -78 M | -78 M | -78 M | -78 M | -46 M | -46 M | -46 M | -46 M | -22.6 M | -22.6 M | -22.6 M | -22.6 M | -10 M | -10 M | -10 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
40.5 M | 48.6 M | 55.5 M | 62.4 M | 67 M | 74.4 M | 81.2 M | 90 M | 98.2 M | 109 M | 74.1 M | 74.1 M | 74.1 M | 74.1 M | 87.8 M | 87.8 M | 87.8 M | 87.8 M | 67.3 M | 67.3 M | 67.3 M | 67.3 M | 69.1 M | 69.1 M | 69.1 M | 69.1 M | 36.6 M | 36.6 M | 36.6 M | 36.6 M | 43.6 M | 43.6 M | 43.6 M | 43.6 M | 11.6 M | 11.6 M | 11.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
36 M | 44.4 M | 50.6 M | 55.9 M | 62.5 M | 69.7 M | 67.8 M | 75.6 M | 85.8 M | 93.1 M | 59.2 M | 59.2 M | 59.2 M | 59.2 M | 70.1 M | 70.1 M | 70.1 M | 70.1 M | 59.8 M | 59.8 M | 59.8 M | 59.8 M | 62.5 M | 62.5 M | 62.5 M | 62.5 M | 31 M | 31 M | 31 M | 31 M | 41.5 M | 41.5 M | 41.5 M | 41.5 M | 9.33 M | 9.33 M | 9.33 M | - | 155 K | - | - | - | 166 K | - | - | - | - | - | - | - |
Buchwert |
29 M | 39 M | 46.2 M | 52.8 M | 57.2 M | 65.2 M | 70.9 M | 78.7 M | 87.7 M | 95.7 M | 60.1 M | 60.1 M | 60.1 M | 60.1 M | 75.6 M | 75.6 M | 75.6 M | 75.6 M | 57.6 M | 57.6 M | 57.6 M | 57.6 M | 60.9 M | 60.9 M | 60.9 M | 60.9 M | 29.6 M | 31.1 M | 36.6 M | 36.6 M | 39.7 M | 43.6 M | 43.6 M | 43.6 M | 11.6 M | 11.6 M | 11.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
29 M | 39 M | 46.2 M | 52.8 M | 57.2 M | 65.2 M | 70.9 M | 78.7 M | 87.7 M | 95.7 M | 60.1 M | 60.1 M | 60.1 M | 60.1 M | 75.6 M | 75.6 M | 75.6 M | 75.6 M | 57.6 M | 57.6 M | 57.6 M | 57.6 M | 60.9 M | 60.9 M | 60.9 M | 60.9 M | 29.6 M | 29.6 M | 29.6 M | 29.6 M | 39.7 M | 39.7 M | 39.7 M | 39.7 M | -8.05 M | -8.05 M | -8.05 M | - | -4.36 M | - | - | - | -3.56 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung